Candriam Equities L Oncology Impact V Fonds
2.179,89
USD
-22,94
USD
-1,04
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Eli Lilly and Co | US5324571083 | 5,50% |
| AstraZeneca PLC | GB0009895292 | 4,95% |
| Merck & Co Inc | US58933Y1055 | 4,78% |
| Amgen Inc | US0311621009 | 4,78% |
| Roche Holding AG | CH0012032048 | 4,57% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 4,46% |
| Gilead Sciences Inc | US3755581036 | 4,18% |
| Novartis AG Registered Shares | CH0012005267 | 4,06% |
| Novo Nordisk AS Class B | DK0062498333 | 4,01% |
| Hologic Inc | US4364401012 | 3,96% |
| Sonstige | 54,75% |